NCT04254224 (SCANDIV-II) is a clinical trial of colon resection, stoma in Diverticulitis Colon, sponsored by Uppsala University.

Who is sponsoring NCT04254224?

NCT04254224 is sponsored by Uppsala University.

What drugs are being tested in NCT04254224?

Interventions in NCT04254224: colon resection, stoma.

What condition does NCT04254224 study?

NCT04254224 studies Diverticulitis Colon.

Is NCT04254224 still recruiting?

NCT04254224 is currently status unknown. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT04254224: SCANDIV-II

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Scandinavian Diverticulitis Trial SCANDIV-II

Status unknown Last updated 5 February 2020

What this trial tests

trial testing colon resection, stoma in Diverticulitis Colon in 500 participants. Status unknown.

Timeline

10 April 2018

Primary endpoint
10 April 2022

10 September 2024

Quick facts

Lead sponsor	Uppsala University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	10 April 2018
Primary completion	10 April 2022
Estimated completion	10 September 2024
Sites	1 location across Sweden

Drugs / interventions tested

colon resection, stoma

Conditions studied

Diverticulitis Colon — all drugs for Diverticulitis Colon →

Sponsor

Uppsala University

Who can join

18 and older, any sex, with Diverticulitis Colon. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study focuses on the treatment for complicated diverticulitis classified as Hinchey I-IV. The aim of this prospective observational study is to evaluate type of treatment and the success rate of treatment in acute complicated diverticulitis (ACD) at participating hospitals in Sweden and Norway. Furthermore, the effects on quality of life for this patient group will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Uppsala University trials

Trials by the same sponsor.

NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04254224 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uppsala University
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04254224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing